A child balanced on a BMI scale, symbolizing balanced sedation.

Underweight and Overweight: How BMI Impacts Sedation in Children with Cancer

Author's portrait.
Samir D’Costa in Health & Wellness December 2025 • 4 min read.

"A new study reveals the impact of BMI on propofol dosing and adverse events during procedural sedation in children with cancer, highlighting unique risks for underweight patients."


Ensuring the safety of children undergoing medical procedures is paramount, especially when sedation is involved. For children with cancer, who often require frequent lumbar punctures and bone marrow aspirations, procedural sedation is a common necessity. However, the unique health profiles of these young patients, particularly their body mass index (BMI), can significantly influence the effectiveness and safety of sedation.

Obesity, a prevalent concern among children, has been previously linked to increased complications during pediatric procedural sedation. Yet, the risks associated with being underweight have remained largely unexplored. A recent study sheds light on this critical area, investigating the connection between BMI, sedation dosing, and adverse events in children with cancer across a spectrum of BMIs.

This article delves into the findings of this important research, offering insights into how BMI affects propofol dosing—a common sedative—and the occurrence of adverse events. Understanding these nuances is essential for clinicians to optimize sedation strategies, ensuring the well-being of every child undergoing these necessary procedures.

BMI and Sedation: Key Findings for Pediatric Cancer Patients

A child balanced on a BMI scale, symbolizing balanced sedation.

The study, encompassing 1976 patients aged 2 to 21 years with oncologic diagnoses, examined the impact of BMI on propofol dosing and adverse events during lumbar punctures and/or bone marrow aspirations. Weight categories were defined by BMI percentile: underweight (<5%), normal weight (5% to 85%), overweight (>85%), and obese (>95%).

One of the most striking findings was the difference in propofol dosing based on BMI. Children who were overweight or obese required less propofol compared to those with normal weight. This suggests that clinicians can potentially reduce the risks associated with sedating obese patients by adjusting the dosage accordingly.

  • Propofol Dosing: Overweight and obese children needed less propofol than normal weight children.
  • Adverse Events: Underweight children experienced a higher rate of adverse events.
  • No Difference in Some Groups: No difference in propofol dosing between normal and underweight children.
However, the study also revealed a concerning trend: underweight children experienced a higher proportion of adverse events compared to those with normal weight. This occurred despite receiving a similar amount of sedation, highlighting a previously unacknowledged risk factor. In contrast, overweight and obese patients did not show an increase in adverse events.

Clinical Implications and Future Directions

The implications of this study are significant for clinical practice. Clinicians should be particularly vigilant when sedating underweight children, as they may be more susceptible to adverse events even with standard propofol doses. Further research is needed to understand the underlying mechanisms behind this increased risk and to develop tailored sedation protocols for underweight children with cancer. By recognizing and addressing these BMI-related differences, healthcare providers can enhance the safety and well-being of all children undergoing procedural sedation.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

1

What is the main focus of the recent study regarding children with cancer and sedation?

The primary focus is on the impact of Body Mass Index (BMI) on propofol dosing and adverse events during procedural sedation, such as lumbar punctures and bone marrow aspirations, in children with cancer. The study aimed to highlight the unique risks associated with underweight patients in this context.

2

How does BMI affect propofol dosing in pediatric cancer patients, according to the study?

The study found that overweight and obese children required less propofol compared to those with normal weight. However, there was no difference in propofol dosing between normal weight and underweight children. This suggests a need for clinicians to adjust propofol dosages, particularly for obese patients, to mitigate potential risks.

3

What adverse events were more common in children with specific BMI during sedation, and what does this imply?

Underweight children experienced a higher rate of adverse events during sedation, while overweight and obese patients did not show an increase. This implies that clinicians must be especially cautious when sedating underweight children, even with standard propofol doses. This highlights a previously unrecognized risk factor linked to BMI in pediatric cancer patients undergoing sedation.

4

What are the key weight categories defined by BMI percentile used in the study?

The study categorized patients based on BMI percentile into four groups: underweight (<5%), normal weight (5% to 85%), overweight (>85%), and obese (>95%). These categories allowed researchers to analyze the relationship between BMI and sedation outcomes effectively.

5

What are the implications of this research for clinicians and what future directions are suggested?

The study's findings underscore the need for clinicians to be particularly vigilant when sedating underweight children with cancer, as they are more susceptible to adverse events. The research suggests a need for further studies to determine the mechanisms behind these risks. This will assist in the development of tailored sedation protocols for underweight children, ultimately improving their safety and well-being during procedures involving sedation, specifically with Propofol.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.